• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login

    Investing News NetworkYour trusted source for investing success

    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    BioStem Receives Prescription Drug Repackager Permit for Subsidiary

    Bryan Mc Govern
    Mar. 27, 2017 08:24AM PST
    Pharmaceutical Investing

    BioStem Technologies announced its subsidiary Qualified Pharma Ingredients received a Prescription Drug Repackager permit from the Florida Department of Business & Professional Regulation.

    BioStem Technologies (OTCPINK:BSEM) announced its subsidiary Qualified Pharma Ingredients received a Prescription Drug Repackager permit from the Florida Department of Business & Professional Regulation.
    As quoted in the press release:

    This license will allow QPI to supply superior qualified products to the Pharmaceutical Compounding and Manufacturing industries, using the leverage of QPI’s strategic partnership and industry experience. The company has a network of pharmacies that are ready to place orders. Now that QPI has obtained its necessary State permit, the team will begin the process of filing for permits in all states to which Active Pharmaceutical Ingredients will be shipped.
    “BioStem Technologies, as a whole, is dedicated to superior quality. Qualified Pharma Ingredients takes the term ‘superior quality’ to new heights. We realized that the lack of consistency and quality systems used by current API suppliers has led to recalls and adverse effects. Therefore, QPI was formed to lead the future of the Active Pharmaceutical Ingredients industry. Applying our pharmaceutical manufacturing and quality backgrounds, we have exceeded all required standards. QPI has found a way to excel in quality while remaining at a competitive price,” said Henry “Chip” Van Vurst, BioStem Technologies, CEO.
    About BioStem Technologies, Inc. (OTCPINK:BSEM): BioStem Technologies, Inc. (OTCPINK:BSEM) is in the business of regenerative medicine and antiaging strategies throughout the United States, Europe, and Mexico. The Company’s mission is to conquer the effects of biological aging (and related acute disease), and its strategy is to discover, develop, produce, and deliver the most effective stem cell and wellness products in the world. The Company is comprised of a diverse group of scientists, physicians, and industry visionaries who are creating innovative products for helping customers live their best, feel their best, and be their best. The company operates six strategic business units — BioStem Cell Therapy, BioStem Wellness, BioStem Pharmaceuticals, Qualified Pharma Ingredients, BioBlue Technologies, and BioStem International — providing a diversified line of products and services that include: clinical stem cell therapy, stem cell R&D, state-of-the-art laboratory services, pharmaceuticals, nutraceuticals, cosmeceuticals, API repackaging, and medical tourism.

    Click here to read the full press release.

    pharmaceutical investingregenerative medicineeuropestem cell therapycell therapypharmaceutical ingredients
    The Conversation (0)
    Go Deeper
    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Invion Limited

     
    IVX:AU

    Cardiol Therapeutics

     
    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×